---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-023426"
form_type: "8-K"
ticker: "CCRN"
cik: "0001141103"
company_name: "CROSS COUNTRY HEALTHCARE INC"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:38:57.803438+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cross Country Healthcare shareholders elect all directors, approve auditor, say-on-pay, and 2024 incentive plan

## Summary
- All eight director nominees elected with majority votes; Gale Fitzgerald received ~25.1M for vs ~4.5M against.
- Ratification of Deloitte & Touche as auditor for FY2024 approved with 31.1M votes for (95.7% of cast).
- Advisory vote on executive compensation approved with 28.2M for (95.3% of votes cast).
- 2024 Omnibus Incentive Plan approved with 27.7M for (93.7% of votes cast).

## SEC filing metadata
- accession: 0001628280-24-023426
- form_type: 8-K
- ticker: CCRN
- cik: 0001141103
- company_name: CROSS COUNTRY HEALTHCARE INC
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1141103/000162828024023426/0001628280-24-023426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1141103/000162828024023426/ccrn-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-023426
- JSON: https://secwatch.observer/filing/0001628280-24-023426.json
- Plain text: https://secwatch.observer/filing/0001628280-24-023426.txt

## Key facts
- Shareholder Votes
  CROSS COUNTRY HEALTHCARE INC shareholders approved Approval of the Company's 2024 Omnibus Incentive Plan at the 2024-05-14 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: The approval of the Company's 2024 Omnibus Incentive Plan was approved as follows: For Against Abstentions Broker Non-Votes 27,695,632 1,872,698 132,656 1,934,784
  evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000162828024023426/0001628280-24-023426-index.htm
- Shareholder Votes
  CROSS COUNTRY HEALTHCARE INC shareholders approved Election of directors listed below for a one-year term ending in 2025 at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: A proposal to elect the directors listed below for a one-year term ending in 2025 or until their successors are duly elected and qualified was approved with the following vote: Director For Against Abstentions Broker Non-Votes Kevin C. Clark 28,900,538 796,241 4,207 1,934,784 Dwayne Allen 29,624,102 72,687 4,197 1,934,784 Venkat Bhamidipati 29,533,683 73,844 93,459 1,934,784 W. Larry Cash 28,928,170 768,626 4,190 1,934,784 Gale Fitzgerald 25,145,571 4,461,981 93,434 1,934,784 John A. Martins 29,041,721 563,565 95,700 1,934,784 Dr. Janice E. Nevin, MD, MPH 28,814,626 882,196 4,164 1,934,784 Mark Perlberg, JD 28,354,730 1,342,067 4,189 1,934,784
  evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000162828024023426/0001628280-24-023426-index.htm
- Shareholder Votes
  CROSS COUNTRY HEALTHCARE INC shareholders approved Ratification of the appointment of Deloitte & Touche as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: The ratification of the appointment of Deloitte & Touche as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was approved as follows: For Against Abstentions Broker Non-Votes 31,129,700 495,366 10,704 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000162828024023426/0001628280-24-023426-index.htm
- Shareholder Votes
  CROSS COUNTRY HEALTHCARE INC shareholders approved Advisory (non-binding) vote on compensation of named executive officers at the 2024-05-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the votes set forth below: For Against Abstentions Broker Non-Votes 28,173,257 1,401,470 126,259 1,934,784
  evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000162828024023426/0001628280-24-023426-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.